Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Treatment of localized renal cell cancer
View through CrossRef
The incidence of localized renal cell carcinoma (RCC) has increased due to the widespread use of abdominal imaging, often for unrelated conditions. Despite improved understanding of the natural history of slow growth in many tumours and the impact of ageing and co-morbidities on patient survival, RCC is still the most lethal of genitourinary cancers and surgery remains the mainstay of treatment. Localized RCC is defined as stages T1-2 N0 M0. The relatively safe needle core biopsy is increasingly used, especially for small renal masses (SRMs), as we now know that up to 30% are benign and that RCC subtypes differ in biology and behaviour. Radical nephrectomy, either performed by open or laparoscopic technique, is indicated for stage T2 tumours or when partial nephrectomy (PN) is not believed to be feasible.
Title: Treatment of localized renal cell cancer
Description:
The incidence of localized renal cell carcinoma (RCC) has increased due to the widespread use of abdominal imaging, often for unrelated conditions.
Despite improved understanding of the natural history of slow growth in many tumours and the impact of ageing and co-morbidities on patient survival, RCC is still the most lethal of genitourinary cancers and surgery remains the mainstay of treatment.
Localized RCC is defined as stages T1-2 N0 M0.
The relatively safe needle core biopsy is increasingly used, especially for small renal masses (SRMs), as we now know that up to 30% are benign and that RCC subtypes differ in biology and behaviour.
Radical nephrectomy, either performed by open or laparoscopic technique, is indicated for stage T2 tumours or when partial nephrectomy (PN) is not believed to be feasible.
Related Results
Infectious complications renal disease
Infectious complications renal disease
Abstract
This book considers the aetiological factors that render renal patients at risk of infection and covers the infectious complications of the major modalities...
The patient with myeloma
The patient with myeloma
Renal impairment is a common feature of multiple myeloma and often the presenting symptom of a patient with symptomatic myeloma. ‘Myeloma kidney’ results from the excess of immunog...
Rapidly Progressive Glomerulonephritis
Rapidly Progressive Glomerulonephritis
Abstract
Rapidly Progressive Glomerulonephritis is one of the most exciting areas in renal medicine. The disease usually presents acutely, and leads to end stage ren...
Prostate Cancer: the facts
Prostate Cancer: the facts
Abstract
Prostate cancer is the second leading cause of cancer death in men. Figures from the US show that the average male stands a one in five chance of developing...
Fabry disease
Fabry disease
Fabry disease is a rare X-linked lysosomal storage disorder in which deficiency of alpha-galactosidase A leads to accumulation of substrate, mostly globotriaosylceramide (Gb3), whi...
Treatment of ANCA-associated vasculitis
Treatment of ANCA-associated vasculitis
The goals of treatment in anti-neutrophil cytoplasm antibody (ANCA) vasculitis are to stop vasculitic activity, to prevent vasculitis returning, and to address longer-term comorbid...
Liver Cancer
Liver Cancer
Primary liver cancer is the sixth most frequently occurring cancer in the world and the second most common in terms of cancer deaths. The global burden of liver cancer is borne pri...
Testicular Cancer
Testicular Cancer
Testicular cancer is a rare cancer in the general population, but is the most common neoplasm among young men in many countries. It has one of the highest heritabilities of all can...